Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreal Avastin vs conventional treatment for proliferative diabetic retinopathy
2007-000658-30Phase 2Completed
- Sponsor
- Royal Victoria Eye and Ear Hospital
- Start
- Feb 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial of bevacizumab in proliferative diabetic retinopathy (PDR) (2 arms), sponsored by Royal Victoria Eye and Ear Hospital. Primary endpoint: Effectiveness of intravitreal bevacizumab vs conventional treatment. Started Feb 2007; status: completed.
02
Drugs
bevacizumab
03
Conditions
proliferative diabetic retinopathy (PDR)
Beyond the preview
Go deeper on 2007-000658-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000658-30.